News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Guselkumab safe, well tolerated in patients with psoriatic arthritis
10 Dec 2021
byStephen Padilla
Treatment with the monoclonal antibody targeting interleukin [IL]-23p19 guselkumab 100 mg, given either every 4 (Q4W) or 8 weeks (Q8W), is well tolerated in patients with psoriatic arthritis (PsA), with no new safety concerns through 1 year, according to pooled results of the DISCOVER-1 and DISCOVER-2 phase III trials.
10 Dec 2021

Carbocisteine, gingko leaf extract boost milrinone’s efficacy against COPD complicated by PAH
09 Dec 2021
The combination of carbocisteine, gingko leaf extract, and milrinone yields significant clinical improvement in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD), a recent study has found. In turn, this treatment regimen also leads to better patient quality of life.
09 Dec 2021







